Duchesnay
Guylaine Pelchat serves as a Conseillère en sciences pharmaceutiques and Director of QA Compliance at Duchesnay since June 2011. Prior to this role, Guylaine held the position of Manager QA & Compliance at Sanofi from January 2001 to June 2011 and worked as a QA Manager at Novopharm from 1994 to 2001. Guylaine Pelchat holds a Bachelor of Science degree in Biochemistry from the Université du Québec à Montréal (UQAM).
Duchesnay
The multinational Duchesnay with its affiliated companies is headquartered in Blainville, Quebec. The group consists of five pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad: - Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; - Médunik Canada and Medunik USA, which provide treatments for rare diseases; and - Analog Pharma, an American generic drugs company, specializing in authorized generics and orphan drugs. From its state-of-the-art manufacturing plant in Blainville, Quebec, Duchesnay exports its innovative treatments to more than 50 countries. Duchesnay and Medunik, through their proprietary research and development, and through partnerships, offer innovative treatments for a variety of medical conditions in women’s health, urology, oncology as well as for rare diseases. The group of companies recognizes the dedication and professionalism of its employees and promotes a positive work culture and flexible work environment. It is deeply committed to environmental responsibility and giving back to the community through the support of various charitable organizations.